J&J, Glaxo are tops in social media, but smaller drugmakers rate highly, too

IMS Health: Pharma Should Make Better Use of Social Media To Engage Patients and Improve the Use of Medicines

13/12/2014

Standard Social Media Practices Are Risky For Big Pharma – Law360

13/12/2014

J&J, Glaxo are tops in social media, but smaller drugmakers rate highly, too

It’s no revelation that pharma is behind the curve when it comes to social media. Consider yourselves fortunate, then, that the IMS Institute for Healthcare Informatics chose to delve into the subject.

Source: www.fiercepharma.com

IMS Health: Pharma Should Make Better Use of Social Media To Engage Patients and Improve the Use of Medicines

Standard Social Media Practices Are Risky For Big Pharma – Law360

IMS Health: Pharma Should Make Better Use of Social Media To Engage Patients and Improve the Use of Medicines

Standard Social Media Practices Are Risky For Big Pharma – Law360

lionelreichardt

Articles similaires

« #MoiPatient, j’aimerais que l’on puisse dupliquer notre beau système de santé sur d’autres contrées qui sont plus démunies », Pascale Barre, Responsable des relations dermatologues chez Pierre Fabre